This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Sagli G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901–1928.
Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410–2414.
Haskovec C, Ponzetto C, Polak J, Maritano D, Zemanova Z, Serra A et al. P230 BCR/ABL protein may be associated with an acute leukaemia phenotype. Br J Haematol 1998; 103: 1104–1108.
Wada H, Mizutani S, Nishimura J, Usuki Y, Kohsaki M, Komai M et al. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer Res 1995; 55: 3192–3195.
Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero I et al. Disruption of the BCL11B gene through inv14(q11.2;q32.31) results in expression of BCL11B–TCRD fusion transcripts and is associated with absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005; 19: 201–208.
Jeffs AR, Benjes SM, Smith TL, Sowerby SJ, Morris CM . The BCR gene recombines preferentially with Alu elements in complex BCR–ABL translocations of chronic myeloid leukaemia. Hum Mol Genet 1998; 7: 767–776.
Zhang JG, Goldman JM, Cross N . Characterization of genomic BCR–ABL breakpoints in chronic myeloid leukaemia by PCR. Br J Haematol 1995; 90: 138–146.
Jiang XY, Trujillo JM, Liang JC . Chromosomal breakpoints within the first intron of the ABL gene are nonrandom in patients with chronic myelogenous leukemia. Blood 1990; 76: 597–601.
Waller CF, Dennebaum G, Feldmann C, Lange W . Long-template DNA polymerase chain reaction for the detection of the bcr/abl translocation in patients with chronic myelogenous leukaemia. Clin Cancer Res 1999; 5: 4146–4151.
Verstovsek S, Lin H, Kantarjian H, Saglio G, De Micheli D, Pane F et al. Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR–ABL mRNA and undetectable p230 BCR–ABL protein may predict indolent course. Cancer 2002; 94: 2416–2425.
Acknowledgements
We are grateful to Professor Dr N Blanckaert for the continuous support, to Annemarie Wijkhuijs and Daniëlle Jacobs for their technical assistance and to Marieke Comans-Bitter for preparation of the figures. We thank Dr Hiroshi Wada who kindly donated the AR230 cell line. This work was supported by a grant of the IGA MZ CR: NC/7560-3.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boeckx, N., Jansen, M., Haskovec, C. et al. Identification of e19a2 BCR–ABL fusions (μ-BCR breakpoints) at the DNA level by ligation-mediated PCR. Leukemia 19, 1292–1295 (2005). https://doi.org/10.1038/sj.leu.2403761
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403761